These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 32919977)

  • 21. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
    Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.
    Shabbir S; Raza MH; Arshad M; Khan MJ
    Arch Virol; 2021 Aug; 166(8):2109-2117. PubMed ID: 33950288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity.
    Vanderbeke L; Van Mol P; Van Herck Y; De Smet F; Humblet-Baron S; Martinod K; Antoranz A; Arijs I; Boeckx B; Bosisio FM; Casaer M; Dauwe D; De Wever W; Dooms C; Dreesen E; Emmaneel A; Filtjens J; Gouwy M; Gunst J; Hermans G; Jansen S; Lagrou K; Liston A; Lorent N; Meersseman P; Mercier T; Neyts J; Odent J; Panovska D; Penttila PA; Pollet E; Proost P; Qian J; Quintelier K; Raes J; Rex S; Saeys Y; Sprooten J; Tejpar S; Testelmans D; Thevissen K; Van Buyten T; Vandenhaute J; Van Gassen S; Velásquez Pereira LC; Vos R; Weynand B; Wilmer A; Yserbyt J; Garg AD; Matthys P; Wouters C; Lambrechts D; Wauters E; Wauters J
    Nat Commun; 2021 Jul; 12(1):4117. PubMed ID: 34226537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
    Ramasamy S; Subbian S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19.
    Ricciotti E; Laudanski K; FitzGerald GA
    Adv Biol Regul; 2021 Aug; 81():100818. PubMed ID: 34303107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid evolution of our understanding of the pathogenesis of COVID-19: Implications for therapy.
    Mustafa F; Giles R; Pepper MS
    S Afr Med J; 2020 Oct; 110(12):1180-1185. PubMed ID: 33403962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Impaired Inflammatory and Innate Immune Response in COVID-19.
    Park SH
    Mol Cells; 2021 Jun; 44(6):384-391. PubMed ID: 34098591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.
    Schönrich G; Raftery MJ; Samstag Y
    Adv Biol Regul; 2020 Aug; 77():100741. PubMed ID: 32773102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.
    Ricke DO
    Front Immunol; 2021; 12():640093. PubMed ID: 33717193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
    Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
    Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophils and COVID-19: The road so far.
    Cavalcante-Silva LHA; Carvalho DCM; Lima ÉA; Galvão JGFM; da Silva JSF; Sales-Neto JM; Rodrigues-Mascarenhas S
    Int Immunopharmacol; 2021 Jan; 90():107233. PubMed ID: 33290963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.
    Jordan SC
    Clin Exp Immunol; 2021 Jun; 204(3):310-320. PubMed ID: 33534923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease.
    Peñaloza HF; Lee JS; Ray P
    PLoS Pathog; 2021 Sep; 17(9):e1009850. PubMed ID: 34473802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
    J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.
    Kosyreva A; Dzhalilova D; Lokhonina A; Vishnyakova P; Fatkhudinov T
    Front Immunol; 2021; 12():682871. PubMed ID: 34040616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients.
    Hammoudeh SM; Hammoudeh AM; Bhamidimarri PM; Al Safar H; Mahboub B; Künstner A; Busch H; Halwani R; Hamid Q; Rahmani M; Hamoudi R
    Front Immunol; 2021; 12():595150. PubMed ID: 34262555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response to COVID-19 infection: a double-edged sword.
    Saad N; Moussa S
    Immunol Med; 2021 Sep; 44(3):187-196. PubMed ID: 33444511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
    Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
    Front Immunol; 2020; 11():588724. PubMed ID: 33117402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.